+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Therapeutics Market by Therapeutic Area, Product Type, Distribution Channel, End-User - Global Forecast to 2030- Product Image
Women's Health Therapeutics Market by Therapeutic Area, Product Type, Distribution Channel, End-User - Global Forecast to 2030- Product Image
Sale

Women's Health Therapeutics Market by Therapeutic Area, Product Type, Distribution Channel, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666342
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Women's Health Therapeutics Market grew from USD 72.21 billion in 2024 to USD 80.11 billion in 2025. It is expected to continue growing at a CAGR of 10.84%, reaching USD 133.97 billion by 2030.

Introduction to the Evolution of Women's Health Therapeutics

Women’s health therapeutics has entered a pivotal era characterized by rapid innovation, shifting regulatory priorities, and an increasingly discerning patient population. As biopharmaceutical companies pursue targeted therapies across oncology, endocrine disorders, and reproductive health, decision-makers require a panoramic view of market drivers, competitive dynamics, and growth enablers.

This executive summary distills the essential developments shaping the global landscape, offering strategic context and actionable insights. By framing the key trends in research and development, policy evolution, and healthcare delivery, this introduction sets the stage for a deeper exploration of transformative shifts, segment-specific intelligence, and regional variations. Our objective is to equip stakeholders-from investors and product developers to healthcare providers and payers-with the clarity needed to navigate an environment defined by both opportunity and complexity.

Pivotal Shifts Reshaping the Therapeutic Landscape

The therapeutic landscape for women’s health has undergone profound transformation, driven by breakthroughs in biologics, precision medicine, and digital health platforms. Advances in monoclonal antibodies for hormone-sensitive breast cancer and novel nonhormonal formulations for menopausal support exemplify how technology is redefining treatment paradigms.

Meanwhile, regulatory agencies have introduced accelerated approval pathways for therapies addressing unmet needs, signaling a shift toward expedited access. Patient empowerment has also gained momentum, fueled by telemedicine and wearable monitoring devices that enhance adherence and outcomes. Collectively, these factors have converged to reshape clinical development strategies, drive strategic partnerships, and elevate the importance of patient-centric trial designs.

Unraveling the Cumulative Impact of US Tariffs in 2025

Recent changes to the United States tariff framework have sent ripples across the women’s health supply chain. Increased duties on imported active pharmaceutical ingredients and specialized medical devices have elevated manufacturing costs, prompting some companies to reassess their sourcing strategies. This realignment has far-reaching implications for pricing structures, with potential downstream effects on reimbursement negotiations and patient access.

Domestic producers may experience temporary relief as local manufacturing gains appeal, but supply chain resilience remains a concern given the globalized nature of raw material procurement. In response, stakeholders are exploring collaborative models, such as shared manufacturing hubs and regional distribution centers, to mitigate cost pressures and maintain uninterrupted access to critical therapeutics.

In-Depth Segmentation Reveals Nuanced Market Dynamics

Understanding market dynamics requires a granular view of therapeutic areas and product categories. Within oncology, breast cancer treatments are subtyped by HER2 positive, hormone receptor positive, and triple negative profiles, while cervical, endometrial, and ovarian cancers present distinct unmet needs. Contraceptive options range from barrier methods and intrauterine devices to implants, injectables, pills, and sterilization, reflecting diverse patient preferences and risk profiles. Gynecological disorders such as endometriosis, pelvic inflammatory disease, polycystic ovary syndrome, and uterine fibroids demand specialized interventions tailored to severity and symptomatology. Menopausal therapy segmentation highlights botanical supplements, hormone replacement therapies including estrogen, estrogen plus progestin, and tibolone, as well as nonhormonal alternatives. Osteoporosis management spans bisphosphonates, denosumab, parathyroid hormone analogues, and selective estrogen receptor modulators.

When examining product types, biologics such as monoclonal antibodies, recombinant proteins, and vaccines command significant investment, while medical devices covering diagnostic, monitoring, and therapeutic functions integrate digital connectivity. Traditional drugs in both branded and generic forms remain foundational. Distribution channels extend from drug stores and retail pharmacies to hospital and online pharmacy models, each offering unique value propositions. End users including clinics, homecare providers, hospitals, and specialty centers shape demand patterns and influence service delivery models. Together, these layers of segmentation reveal where innovation is converging on patient needs and where strategic partnerships can unlock new growth avenues.

Regional Variations Defining Growth Pathways

Regional markets exhibit distinctive trajectories shaped by healthcare infrastructure, regulatory landscapes, and demographic shifts. In the Americas, robust R&D investment and well-established reimbursement frameworks have accelerated adoption of advanced biologics and digital therapeutics. Market consolidation among distributors has streamlined logistics, yet patient access challenges persist in underserved areas, driving interest in telehealth solutions.

Europe, the Middle East & Africa present a mosaic of matured and emerging markets. Western European countries benefit from centralized procurement models and comprehensive coverage policies, while Middle Eastern nations are investing heavily in bespoke oncology and reproductive health centers. Across Africa, limited infrastructure and budget constraints underscore the importance of cost-effective generics and mobile health initiatives.

Asia-Pacific stands out for dynamic growth fueled by rising healthcare spending and government programs addressing women’s health. Local manufacturers are partnering with global players to enhance technology transfer, and digital platforms are bridging gaps in rural areas. As regulatory harmonization efforts progress, this region is poised to become a hub for clinical trials and manufacturing expansion.

Leading Innovators Driving Competitive Advantage

The competitive landscape is anchored by global biopharmaceutical leaders that have consistently directed resources toward women’s health pipelines. Pioneers in monoclonal antibody development have reinforced their positions through strategic licensing agreements and targeted acquisitions. Innovators in hormone replacement therapy are differentiating portfolios by advancing nonhormonal modalities and botanical formulations backed by robust clinical evidence.

Device manufacturers are forging collaborations to embed digital monitoring capabilities into therapeutic offerings, enhancing patient engagement and real-time data capture. Generic drug suppliers are leveraging efficient manufacturing processes to maintain affordability, particularly in markets with constrained reimbursement. Meanwhile, emerging biotech firms are challenging incumbents with breakthrough candidates in endometriosis and uterine fibroid treatment, attracting partnership interest from established players aiming to bolster their mid-stage pipelines.

Strategic Imperatives for Industry Advancement

To capitalize on evolving opportunities, industry leaders should prioritize integrated R&D strategies that combine advanced analytics with patient-centric trial designs. Establishing shared manufacturing networks can enhance supply chain flexibility and reduce exposure to geopolitical risks. Embracing cross-sector alliances with digital health providers will accelerate the rollout of remote monitoring solutions, thereby improving outcomes and adherence.

Engagement with policymakers and payers is essential to shape reimbursement policies that recognize the value of targeted therapies and combination regimens. Investing in health equity programs and community outreach will build brand trust and expand market access in underrepresented segments. By aligning commercial and clinical functions, organizations can streamline go-to-market plans and deliver holistic care pathways that resonate with modern patients.

Rigorous Methodology Underpinning Our Analysis

Our analysis integrates a multi-tiered research framework beginning with exhaustive secondary research across peer-reviewed journals, regulatory filings, and competitive intelligence databases. This desk research laid the groundwork for hypothesis generation and gap identification.

We then conducted primary interviews with oncologists, reproductive health specialists, procurement leaders, and payers across key markets to validate emerging trends and interpret nuanced stakeholder perspectives. Data triangulation ensured consistency between quantitative insights and qualitative narratives. All findings were peer-reviewed by subject-matter experts to enhance accuracy and objectivity, delivering a robust foundation for strategic decision-making.

Synthesis of Key Findings and Implications

The convergence of technological breakthroughs, policy reforms, and shifting patient expectations underscores a defining moment for women’s health therapeutics. This synthesis highlights the critical interplay between advanced biologics, digital platforms, and region-specific market conditions. By leveraging a layered segmentation approach alongside dynamic regulatory insights, stakeholders can pinpoint areas of unmet need and unlock novel pathways for collaboration.

Armed with a clear understanding of tariff impacts, competitive positioning, and actionable recommendations, decision-makers are equipped to navigate complexity with confidence. The insights presented herein will inform strategic investments, guide portfolio prioritization, and foster partnerships that drive both clinical and commercial success in this vital therapeutic domain.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapeutic Area
    • Cancer Therapies
      • Breast Cancer
        • Her2 Positive
        • Hormone Receptor Positive
        • Triple Negative
      • Cervical Cancer
      • Endometrial Cancer
      • Ovarian Cancer
    • Contraceptives
      • Barrier Methods
      • Implant
      • Injectable
      • Iud
      • Pill
      • Sterilization
    • Gynecological Disorders
      • Endometriosis
      • Pelvic Inflammatory Disease
      • Polycystic Ovary Syndrome
      • Uterine Fibroids
    • Menopausal Therapies
      • Botanical Supplements
      • Hormone Replacement Therapy
        • Estrogen
        • Estrogen Plus Progestin
        • Tibolone
      • Nonhormonal Therapies
    • Osteoporosis
      • Bisphosphonates
      • Denosumab
      • Pth Analogues
      • Serms
  • Product Type
    • Biologics
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Devices
      • Diagnostic Devices
      • Monitoring Devices
      • Therapeutic Devices
    • Drugs
      • Branded
      • Generic
  • Distribution Channel
    • Drug Stores
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End-User
    • Clinics
    • Homecare
    • Hospitals
    • Specialty Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Johnson & Johnson
  • Ferring B.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novo Nordisk A/S
  • Gedeon Richter Plc

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Women's Health Therapeutics Market, by Therapeutic Area
8.1. Introduction
8.2. Cancer Therapies
8.2.1. Breast Cancer
8.2.1.1. Her2 Positive
8.2.1.2. Hormone Receptor Positive
8.2.1.3. Triple Negative
8.2.2. Cervical Cancer
8.2.3. Endometrial Cancer
8.2.4. Ovarian Cancer
8.3. Contraceptives
8.3.1. Barrier Methods
8.3.2. Implant
8.3.3. Injectable
8.3.4. Iud
8.3.5. Pill
8.3.6. Sterilization
8.4. Gynecological Disorders
8.4.1. Endometriosis
8.4.2. Pelvic Inflammatory Disease
8.4.3. Polycystic Ovary Syndrome
8.4.4. Uterine Fibroids
8.5. Menopausal Therapies
8.5.1. Botanical Supplements
8.5.2. Hormone Replacement Therapy
8.5.2.1. Estrogen
8.5.2.2. Estrogen Plus Progestin
8.5.2.3. Tibolone
8.5.3. Nonhormonal Therapies
8.6. Osteoporosis
8.6.1. Bisphosphonates
8.6.2. Denosumab
8.6.3. Pth Analogues
8.6.4. Serms
9. Women's Health Therapeutics Market, by Product Type
9.1. Introduction
9.2. Biologics
9.2.1. Monoclonal Antibodies
9.2.2. Recombinant Proteins
9.2.3. Vaccines
9.3. Devices
9.3.1. Diagnostic Devices
9.3.2. Monitoring Devices
9.3.3. Therapeutic Devices
9.4. Drugs
9.4.1. Branded
9.4.2. Generic
10. Women's Health Therapeutics Market, by Distribution Channel
10.1. Introduction
10.2. Drug Stores
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
11. Women's Health Therapeutics Market, by End-User
11.1. Introduction
11.2. Clinics
11.3. Homecare
11.4. Hospitals
11.5. Specialty Centers
12. Americas Women's Health Therapeutics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Women's Health Therapeutics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Women's Health Therapeutics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Johnson & Johnson
15.3.3. Ferring B.V.
15.3.4. Teva Pharmaceutical Industries Ltd.
15.3.5. Pfizer Inc.
15.3.6. Merck & Co., Inc.
15.3.7. AbbVie Inc.
15.3.8. Amgen Inc.
15.3.9. Novo Nordisk A/S
15.3.10. Gedeon Richter Plc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. WOMEN'S HEALTH THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. WOMEN'S HEALTH THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. WOMEN'S HEALTH THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. WOMEN'S HEALTH THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. WOMEN'S HEALTH THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. WOMEN'S HEALTH THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 101. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 102. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 103. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 104. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 105. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 106. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 107. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 108. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 109. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 111. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 112. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 116. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 118. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 122. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 126. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 187. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 188. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 189. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 192. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 193. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 198. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 201. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 229. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 230. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 231. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 232. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 234. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 235. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 236. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 238. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 239. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 243. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 245. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 248. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 249. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 253. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 299. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2030 (USD MILLION)
TABLE 300. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 301. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 302. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 303. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 304. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK WOMEN

Companies Mentioned

The companies profiled in this Women's Health Therapeutics market report include:
  • Bayer AG
  • Johnson & Johnson
  • Ferring B.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novo Nordisk A/S
  • Gedeon Richter Plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 80.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 133.97 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Women Health Therapeutics Market 2024-2028 - Product Image

Women Health Therapeutics Market 2024-2028

  • Report
  • 180 Pages
  • Global
From
Women's Health Therapeutics - Global Strategic Business Report - Product Image

Women's Health Therapeutics - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Gynecology Drugs Market Report 2025 - Product Image

Gynecology Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Women's Health Market by Product Type, Application, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Women's Health Market by Product Type, Application, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From

About the Women Health Therapeutic Market

The Women Health Therapeutic market is a subset of the Women's Health industry, focusing on the development and delivery of treatments and therapies for women's health issues. This market includes a range of products and services, from pharmaceuticals and medical devices to lifestyle and wellness products. It also includes services such as health education, counseling, and support. The goal of the Women Health Therapeutic market is to improve the health and well-being of women by providing access to treatments and therapies that are tailored to their needs. Some of the companies in the Women Health Therapeutic market include Pfizer, Merck, Johnson & Johnson, Novartis, Bayer, and GlaxoSmithKline. These companies are involved in the development and delivery of treatments and therapies for women's health issues, as well as providing health education and support services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.